| MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma D Skiriute, P Vaitkiene, V Saferis, V Asmoniene, K Skauminas, VP Deltuva, ... BMc cancer 12, 1-9, 2012 | 82 | 2012 |
| High CHI3L1 expression is associated with glioma patient survival G Steponaitis, D Skiriutė, A Kazlauskas, I Golubickaitė, R Stakaitis, ... Diagnostic pathology 11, 1-8, 2016 | 60 | 2016 |
| Glioma malignancy-dependent NDRG2 gene methylation and downregulation correlates with poor patient outcome D Skiriutė, G Steponaitis, P Vaitkienė, M Mikučiūnas, K Skauminas, ... Journal of Cancer 5 (6), 446, 2014 | 38 | 2014 |
| Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma D Skiriutė, P Vaitkienė, V Ašmonienė, G Steponaitis, VP Deltuva, ... Journal of neuro-oncology 113, 441-449, 2013 | 38 | 2013 |
| High level of Sema3C is associated with glioma malignancy P Vaitkienė, D Skiriutė, G Steponaitis, K Skauminas, A Tamašauskas, ... Diagnostic Pathology 10, 1-8, 2015 | 28 | 2015 |
| Associations Between TFPI-2 Methylation and Poor Prognosis in Glioblastomas Paulina Vaitkienė, Daina Skiriutė, Kęstutis Skauminas P Vaitkienė, D Skiriutė, K Skauminas, A Tamašauskas Medicina 48 (7), 51, 2012 | 27 | 2012 |
| MMP2 is associated with glioma malignancy and patient outcome R Sincevičiūtė, P Vaitkienė, R Urbanavičiūtė, G Steponaitis, ... International Journal of Clinical and Experimental Pathology 11 (6), 3010, 2018 | 25 | 2018 |
| GFAP expression is influenced by astrocytoma grade and rs2070935 polymorphism M Sereika, R Urbanaviciute, A Tamasauskas, D Skiriute, P Vaitkiene Journal of Cancer 9 (23), 4496, 2018 | 23 | 2018 |
| GATA4 and DcR1 methylation in glioblastomas P Vaitkienė, D Skiriutė, K Skauminas, A Tamašauskas Diagnostic pathology 8, 1-5, 2013 | 20 | 2013 |
| Significance of amphiregulin (AREG) for the outcome of low and high grade astrocytoma patients G Steponaitis, A Kazlauskas, D Skiriute, P Vaitkiene, K Skauminas, ... Journal of Cancer 10 (6), 1479, 2019 | 17 | 2019 |
| Signal transducer and activator of transcription 3 (STAT3) promoter methylation and expression in pituitary adenoma I Valiulyte, G Steponaitis, D Skiriute, A Tamasauskas, P Vaitkiene BMC Medical Genetics 18, 1-7, 2017 | 14 | 2017 |
| The Role of CASC2 and miR-21 Interplay in Glioma Malignancy and Patient Outcome D Skiriute, R Stakaitis, G Steponaitis, A Tamasauskas, P Vaitkiene International journal of molecular sciences 21 (21), 7962, 2020 | 13 | 2020 |
| Association of miR-34a expression with quality of life of glioblastoma patients: a prospective study P Vaitkiene, A Pranckeviciene, R Stakaitis, G Steponaitis, A Tamasauskas, ... Cancers 11 (3), 300, 2019 | 13 | 2019 |
| Does MMP-9 gene polymorphism play a role in pituitary adenoma development? B Glebauskiene, R Liutkeviciene, A Vilkeviciute, L Kriauciuniene, ... Disease Markers 2017, 2017 | 12 | 2017 |
| Testin (TES) as a candidate tumour suppressor and prognostic marker in human astrocytoma G Steponaitis, A Kazlauskas, D Skiriute, I Valiulyte, K Skauminas, ... Oncology Letters 12 (5), 3305-3311, 2016 | 11 | 2016 |
| Unique interplay between molecular miR-181b/d biomarkers and health related quality of life score in the predictive glioma models R Stakaitis, A Pranckeviciene, G Steponaitis, A Tamasauskas, ... International journal of molecular sciences 21 (20), 7450, 2020 | 10 | 2020 |
| Identification of astrocytoma blood serum protein profile P Vaitkiene, R Urbanaviciute, P Grigas, G Steponaitis, A Tamasauskas, ... Cells 9 (1), 16, 2019 | 9 | 2019 |
| MMP-14 and TGFβ-1 methylation in pituitary adenomas K Ruskyte, R Liutkevicienė, A Vilkeviciute, P Vaitkiene, I Valiulytė, ... Oncology Letters 12 (4), 3013-3017, 2016 | 9 | 2016 |
| Identification and comparison of m6A modifications in glioblastoma non-coding RNAs with MeRIP-seq and Nanopore dRNA-seq R Krusnauskas, R Stakaitis, G Steponaitis, K Almstrup, P Vaitkiene Epigenetics 18 (1), 2163365, 2023 | 8 | 2023 |
| N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma P Vaitkiene, I Valiulyte, B Glebauskiene, R Liutkeviciene Diagnostic Pathology 12, 1-8, 2017 | 8 | 2017 |
